Ketamine vs Midazolam on Cognitive Function in Elderly in Elective Surgery Three-Months Postoperatively (ketaminvsMDZ)
Brief Summary
Condition or Disease
- Cognitive Dysfunction
Phase
Study Design
Study type: | Interventional |
---|---|
Status: | Recruiting |
Study results: | No Results Available |
Age: | 60 Years to 85 Years (Adult, Older Adult) |
Enrollment: | 68 () |
Funded by: | Other |
Masking |
Clinical Trial Dates
Start date: | Jan 24, 2021 | |
---|---|---|
Primary Completion: | May 15, 2021 | |
Completion Date: | Jun 20, 2021 | |
Study First Posted: | Oct 21, 2019 | |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Jan 26, 2021 |
Sponsors / Collaborators
Location
Randomized double blind clinical trial. Male and female patients 60-90 years of age scheduled in elective surgery under regional anesthesia and sedation.
The researchers will be double blind and the data analyzer will ignore the drug used ( it it should be midazolam or ketamine in an intravenous infusion). The principal investigator will limit himself to collecting the questionnaires and following up to 3 months. Simple finite randomization in two groups, will be done through envelopes.
The pre-surgical, post-surgical Mini Mental questionnaire will be applied on the first day, 1 month and 3 months. During the trans-anesthetic, hemodynamic variables and anesthetic depth index measurements will be taken, surgical time, estimated bleeding, use of other adjuvant medications, type of surgery and comorbidities will be taken as intervening variables.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 60 |
Maximum Age: | 90 |
This clinical trial is recruiting
Are you interested in participating in this trial or others? We'd love to help.
More Details
NCT Number: | NCT04134052 |
---|---|
Acronym: | ketaminvsMDZ |
Other IDs: | 90129 |
Study URL: | https://ClinicalTrials.gov/show/NCT04134052 |